Lowering Blood Pressure in Primary Care in Vienna (Low BP Vienna)

NCT02377661 Phase 4 COMPLETED

The aim of this prospective, randomised, open-label, multicentre clinical trial is to enhance blood pressure control in primary care by introducing a standardised and simplified titration regime with single pill combinations (SPC), comprising an angiotensin receptor blocker, calcium channel blocker and hydrochlorothiazide.

Details

Lead sponsor	Wilhelminenspital Vienna
Phase	Phase 4
Status	COMPLETED
Enrolment	229
Start date	2015-03
Completion	2017-05-30

Conditions

• Hypertension

Interventions

• Olmesartan medoxomil, amlodipine, hydrochlorothiazide

Primary outcomes

• Achievement of the target office blood pressure (< 140/90 mmHg) — 6 months
  Proportion of patients achieving the target office blood pressure of 140/90 mmHg
• Achievement of the target systolic office blood pressure (< 140 mmHg) — 6 months
  Proportion of patients achieving the target systolic office blood pressure of 140 mmHg
• Achievement of the target diastolic office blood pressure (< 90 mmHg) — 6 months
  Proportion of patients achieving the target diastolic office blood pressure of 90 mmHg

Countries

Austria